Skip to main content




Dr. Sanjeev Munshi has over 25 years of experience in biomedical R&D, business development and licensing, working in large biopharmaceutical and small biotech organizations.

Sanjeev serves as the Chief Business Officer at Greenfire Bio, a privately held biotech focused on advancing FIC products in Oncology. Previously, Sanjeev was Senior VP of human healthcare business and alliances at InveniAI® LLC, an industry leading biotech that leverages artificial intelligence (AI) and machine learning (ML) to transform drug discovery and development. Sanjeev started his pharmaceutical career in drug discovery at Merck and held several leadership roles in drug discovery and business development. Sanjeev headed the department of Protein Sciences and Structural Biology at Merck and was a key contributor to several drug candidates and co-authored 75 publications. As an Executive Director of business development and licensing, Sanjeev led several in-licensing deals across multiple therapeutic areas, established external research collaborations, and managed alliances. Sanjeev holds a Ph.D. in Structural Biology from the Indian Institute of Science, India, and an MBA from Villanova University.